Form4insider filings, from the source

Insider holders · CIK 0001515673

Ultragenyx Pharmaceutical Inc. · RARE

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Emil D KakkisPresident & CEO467,6702,559,7413,027,411Mar 4, 2019 · 5:00 pm ESTForm 4
William AliskiDirector72,61090,350162,960Dec 7, 2018 · 4:12 pm ESTForm 4
Howard HornChief Financial Officer96,295—96,295Aug 4, 2026 · 3:13 pm EDTForm 4
Karah Herdman ParschauerEVP and Chief Legal Officer92,562—92,562Aug 4, 2026 · 3:15 pm EDTForm 4
Thomas Richard KassbergCBO & EVP89,499—89,499Mar 4, 2019 · 5:05 pm ESTForm 4
Shalini SharpCFO & Executive Vice President69,156—69,156Mar 4, 2019 · 5:02 pm ESTForm 4
Theodore Alan HuizengaSVP, Chief Accounting Officer67,863—67,863Sep 15, 2026 · 6:57 pm EDTForm 4
John Richard PinionSee Remarks36,986—36,986Mar 4, 2019 · 5:10 pm ESTForm 4
Jayson Donald Alexander DallasEVP & Chief Commercial Officer23,830—23,830Jun 4, 2018 · 4:50 pm EDTForm 4
Camille L BedrosianEVP and Chief Medical Officer23,364—23,364Mar 4, 2019 · 5:09 pm ESTForm 4
Dennis Karl HuangEVP & Chief Tech Ops Officer21,711—21,711Mar 4, 2019 · 5:12 pm ESTForm 4
Corazon (Corsee) D. SandersDirector21,095—21,095Jun 15, 2026 · 6:50 pm EDTForm 4
Wladimir HogenhuisChief Operating Officer20,000—20,000Mar 4, 2019 · 5:07 pm ESTForm 4
Matthew K FustDirector11,750—11,750Jun 20, 2018 · 6:07 pm EDTForm 4
Sunil AgarwalChief Medical Officer9,136—9,136Aug 23, 2016 · 5:52 pm EDTForm 4
Michael NarachiDirector6,750—6,750Jun 20, 2018 · 6:12 pm EDTForm 4
Lars EkmanDirector6,750—6,750Jun 20, 2018 · 5:57 pm EDTForm 4
Daniel G WelchDirector6,750—6,750Jun 20, 2018 · 5:47 pm EDTForm 4
Clay B SiegallDirector6,750—6,750Jun 20, 2018 · 6:14 pm EDTForm 4
Deborah DunsireDirector4,875—4,875Jun 20, 2018 · 6:16 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.